Topiramate reduces non-convulsive seizures after focal brain ischemia in the rat

Neuroscience Letters

Volumn 430, Issue 1, 2008, Pages 7-12

  Williams, Anthony J ^a   Tortella, Frank C ^a   Gryder, Divina ^a   Hartings, Jed A ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Brain injury; EEG; Focal ischemia; MCAo; Non convulsive; Rat; Seizure; Topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTICONVULSANTS; BRAIN ISCHEMIA; ELECTROENCEPHALOGRAPHY; FRUCTOSE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 37549021131     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.09.052     Document Type: Article

References (35)

1. Annegers J.F., Hauser W.A., Coan S.P., and Rocca W.A. A population-based study of seizures after traumatic brain injuries. N. Engl. J. Med. 338 (1998) 20-24
2. Bialer M., Twyman R.E., and White H.S. Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels. Epilepsy Behav. 5 (2004) 866-872
3. Brunton L., Lazo J., and Parker K. Goodman and Gilman's the Pharmacological Basis of Therapeutics (2006), McGraw-Hill, New York
4. Costa C., Martella G., Picconi B., Prosperetti C., Pisani A., Di Filippo M., Pisani F., Bernardi G., and Calabresi P. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 37 (2006) 1319-1326
5. DeLorenzo R.J., Sombati S., and Coulter D.A. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41 Suppl. 1 (2000) S40-S44
6. Edmonds Jr. H.L., Jiang Y.D., Zhang P.Y., and Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci. 69 (2001) 2265-2277
7. Eyal S., Yagen B., Sobol E., Altschuler Y., Shmuel M., and Bialer M. The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45 (2004) 737-744
8. Grand'Maison F., Reiher J., Leduc C.P., Trojnar M.K., Malek R., Chroscinska M., Nowak S., Blaszczyk B., Czuczwar S.J., Leker R.R., and Neufeld M.Y. Retrospective inventory of EEG abnormalities in partial status epilepticus. Electroencephalogr. Clin. Neurophysiol. 79 (1991) 264-270
9. Gryder D.S., and Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J. Neurosci. 23 (2003) 7069-7074
10. Hartings J.A., Williams A.J., and Tortella F.C. Occurrence of non-convulsive seizures, periodic lateralized epileptiform discharges, and rhythmic delta activity in rat focal ischemia. Exp. Neurol. 179 (2003) 139-149
11. Hoover R.C., Motta M., Davis J., Saatman K.E., Fujimoto S.T., Thompson H.J., Stover J.F., Dichter M.A., Twyman R., White H.S., and McIntosh T.K. Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats. J. Neurotrauma. 21 (2004) 501-512
12. Johannessen S.I. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 38 Suppl. 1 (1997) S18-S23
13. Jordan K. Neurophysiologic monitoring in the neuroscience intensive care unit. Neuro. Crit. Care 13 (1995) 579-627
14. Jordan K. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J. Clin. Neurophysiol. 16 (1999) 14-39
15. Jordan K. Nonconvulsive status epilepticus in acute brain injury. J. Clin. Neurophysiol. 16 (1999) 332-340
16. Jordan K.G., and Hirsch L.J. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 47 Suppl. 1 (2006) 41-45
17. Kockelmann E., Elger C.E., and Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res. 54 (2003) 171-178
18. Nakamura J., Tamura S., Kanda T., Ishii A., Ishihara K., Serikawa T., Yamada J., and Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur. J. Pharmacol. 254 (1994) 83-89
19. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16 (2002) 695-714
20. Shank R.P., Gardocki J.F., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 Suppl. 1 (2000) S3-S9
21. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr. Opin. Pharmacol. 6 (2006) 108-113
22. Tallarida R. Drug Synergism and Dose-Effect Data Analysis (2000), Chapman & Hall
23. Tortella F., Britton P., Williams A., Lu X., and Newman A. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-d-aspartate antagonist. J. Pharmacol. Exp. Ther. 291 (1999) 399-408
24. Vespa P., Nenov V., and Nuwer M. Continuous EEG monitoring in the intensive care unit: early findings and clinical efficacy. J. Clin. Neurophysiol. 16 (1999) 1-13
25. Vespa P., Nuwer M., Nenov V., Ronne-Engstrom E., Hovda D., Bergsneider M., Kelly D., Martin N., and Becker D. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J. Neurosurg. 91 (1999) 750-760
26. Vespa P.M., O'Phelan K., Shah M., Mirabelli J., Starkman S., Kidwell C., Saver J., Nuwer M.R., Frazee J.G., McArthur D.A., and Martin N.A. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60 (2003) 1441-1446
27. Wauquier A., and Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. 24 (1996) 73-77
28. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 Suppl. 1 (2000) S17-S20
29. Williams A.J., Bautista C.C., Chen R.W., Dave J.R., Lu X.C., Tortella F.C., and Hartings J.A. Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats. J. Pharmacol. Exp. Ther. 318 (2006) 947-955
30. Williams A., Dave J., Phillips J., Lin Y., McCabe R., and Tortella F. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-d-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J. Pharmacol. Exp. Ther. 294 (2000) 378-386
31. Williams A.J., Tortella F.C., Lu X.C., Moreton J.E., and Hartings J.A. Anti-epileptic drug treatment of non-convulsive seizures induced by experimental focal brain ischemia. J. Pharmacol. Exp. Ther. 311 (2004) 220-227
32. Yang Y., Li Q., and Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 39 (2000) 881-888
33. Yang Y., Shuaib A., Li Q., and Siddiqui M. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 804 (1998) 169-176
34. Young G.B., Jordan K.G., and Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 47 (1996) 83-89
35. Zhang X., Velumian A.A., Jones O.T., and Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 Suppl. 1 (2000) S52-S60